Unilateral Mandibular Condylar Hyperplasia
Journal Title: International Journal of Medical and Dental Sciences - Year 2017, Vol 6, Issue 2
Abstract
Mandibular condylar hyperplasia is a relatively rare condition with uncertain etiology affecting the condylar head, neck and many a times body and ramus of mandible. The condition causes facial asymmetry, deviation of the jaw, occlusal derangements and articular dysfunction. Radiographic examination plays a critical role in establishing a correct diagnosis. Bone scintigraphy scan has been found to be effective in direct assessment of condyar activity which aids in proper treatment planning. Here, we report a case of unilateral condylar hyperplasia in a 31year old male patient which was diagnosed and corrected with the help of appropriate radiographic examination.
Rectal Foreign Bodies:A Retrospective Study
Background: Reported incidence of rectal foreign bodies is rather rare with only isolated published case reports or case series. Controlled studies of patients with rectal foreign bodies have not been conducted. The appr...
Tissue Engineering- An Art and Science of Regeneration
Tissue engineering is a novel and exciting field that aims to re-create functional, healthy tissues and organs in order to replace diseased, dying, or dead tissues. The association of biomaterials, stem cells, growth and...
A Comparative Evaluation of Efficacy and Safety of Daily Dosing Versus Alternate Day Dosing of Rosuvastatin for Dyslipidemic Patients
Background:Cardiovascular disease (CVD) is the most common contributor of morbidity and mortality in underdeveloped and developing countries and places a huge burden on the society in terms of health care resources and l...
Comparative Analysis of Unilateral Subarachnoid block with Ankle block for elective foot surgery
Background: There are many accepted anesthesia techniques for elective foot surgery ranging from general anesthesia to regional anesthesia, regional anesthesia being the preferred method. Regional anesthesia techniques e...
Need of beta 3 agonist in today’s world as oral hypoglycaemic and antiobesity
no abstract